InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Dorenbaum Alejandro, Directeur Médical. Insider active across 1 company, notably Reneo Pharmaceuticals, Inc.. In total, 2 filings have been recorded. History available since 10 December 2021. The latest transaction was disclosed on 12 August 2022 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Alejandro Dorenbaum is the Chief Medical Officer at Reneo Pharmaceuticals, Inc. He is responsible for leading the company's medical and clinical initiatives. With strong experience in the pharmaceutical sector, he plays a key role in developing new treatments and in Reneo's strategic direction.